See All Slides - tctmd.com

Slides

Presentation TCT 2024

TCT 345: DYNAMX Bioadaptor Stent Implantation for the Treatment of Complex Coronary Lesions: Insights From the DYNAMITE Study

Presenter: Pier Pasquale Leone

October 30, 2024

Presentation TCT 2024

TCT 344: Intravascular Lithotripsy (IVL) Prior to Drug-Coated Balloons (DCB): A Single Center Experience

Presenter: Franz Kleber

October 30, 2024

Presentation TCT 2024

TCT 1290: Transcatheter Rescue Thrombectomy of a Stuck Prosthetic Mitral Valve: A Desperate Measure and a Race Against Time

Presenter: Vidhyakar Rangasamy Balasubramanian

October 30, 2024

Presentation TCT 2024

One-year Outcomes of ACURATE neo2 vs Approved TAVR Devices in All-risk patients with Severe AS: the ACURATE IDE Trial

Presenter: Michael Reardon

October 30, 2024

Presentation TCT 2024

Transcatheter VIV (With Appropriate Leaflet Modification) Will Dominate!

Presenter: Adam Greenbaum

October 30, 2024

Presentation TCT 2024

Re-Do Surgery has Clear Long-Term Advantages and is Preferred!

Presenter: Michael Bowdish

October 30, 2024

Presentation TCT 2024

Electrosurgery Leaflet Modification – Technique and Results After BASILICA

Presenter: Jaffar Khan

October 30, 2024

Presentation TCT 2024

Mechanical Leaflet Modification – Technique and Results After SHORTCUT

Presenter: Danny Dvir

October 30, 2024

Presentation TCT 2024

TCT 915: Predictors of Conduction System Disturbances Resulting in a New Permanent Pacemaker Implantation Within the LANDMARK Trial

Presenter: Pieter Smits

October 30, 2024

Presentation TCT 2024

TCT 916: MÉTIS Study: Modification of NEurological Outcome After TAVR UsIng Sentinel Protection Device

Presenter: Tomas Kovarnik

October 30, 2024

Advertisement

Slides

TCT 345: DYNAMX Bioadaptor Stent Implantation for the Treatment of Complex Coronary Lesions: Insights From the DYNAMITE Study

TCT 344: Intravascular Lithotripsy (IVL) Prior to Drug-Coated Balloons (DCB): A Single Center Experience

TCT 1290: Transcatheter Rescue Thrombectomy of a Stuck Prosthetic Mitral Valve: A Desperate Measure and a Race Against Time

One-year Outcomes of ACURATE neo2 vs Approved TAVR Devices in All-risk patients with Severe AS: the ACURATE IDE Trial

Transcatheter VIV (With Appropriate Leaflet Modification) Will Dominate!

Re-Do Surgery has Clear Long-Term Advantages and is Preferred!

Electrosurgery Leaflet Modification – Technique and Results After BASILICA

Mechanical Leaflet Modification – Technique and Results After SHORTCUT

TCT 915: Predictors of Conduction System Disturbances Resulting in a New Permanent Pacemaker Implantation Within the LANDMARK Trial

TCT 916: MÉTIS Study: Modification of NEurological Outcome After TAVR UsIng Sentinel Protection Device

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content